T: +44 (0) 1794 301052 E: info@ploughshareinnovations.com

Pre-symptomatic Determination of Sepsis

Predictive accuracy of at least 97%

Diagnosed cases of sepsis are exceeding 18 million a year with 1,400 patients dying daily in the developed world. New technologies are urgently required to allow for earlier detection of patients with, or at risk of, sepsis. The described technology allows for the pre-symptomatic diagnosis of sepsis, differentiating the approach from those in current use or development.

About Ploughshare Innovations: harnessing innovation for a better world

Ploughshare is your gateway to a portfolio of world-class life science and other technology solutions from Dstl, the MOD’s research and development division.